| Primary | Procedural Endpoint: Procedure Time From First Incision to Closing. | Characterize procedure time from first incision to closing. | | Posted | | Mean | Standard Deviation | minutes | | During Procedure, Approximately 60 Minutes | | | | ID | Title | Description |
|---|
| OG000 | Treated Participants | Participants in which a device placement was attempted. |
| | | Title | Denominators | Categories |
|---|
| | |
| |
| Primary | Procedural Endpoint: Type of Anesthesia Used | Describe the type of anesthesia used. | | Posted | | Count of Participants | | Participants | | During Procedure, Approximately 60 Minutes | | | | ID | Title | Description |
|---|
| OG000 | Treated Participants | Participants in which a device placement was attempted. |
| | | Title | Denominators | Categories |
|---|
|
| Primary | Procedural Endpoint: Rate of Foley Catheter Use - Intraoperative | Number of participants requiring the use of a foley catheter intra-operatively. | | Posted | | Count of Participants | | Participants | | During Procedure, Approximately 60 Minutes | | | | ID | Title | Description |
|---|
| OG000 | Treated Participants | Participants in which a device placement was attempted. |
| | |
| Primary | Procedural Endpoint: Rate of Foley Catheter Use - Post-operative | Number of participants requiring the use of a foley catheter who were able to void prior to discharge. | | Posted | | Count of Participants | | Participants | | post-operative to discharge | | | | ID | Title | Description |
|---|
| OG000 | Treated Participants | Participants in which a device placement was attempted. |
| | |
| Primary | Procedural Endpoint: Rate of Foley Catheter Use - Post-discharge | Number of participants requiring the use of a foley catheter post-discharge following Bladder Management instructions. | | Posted | | Count of Participants | | Participants | | post discharge | | | | ID | Title | Description |
|---|
| OG000 | Treated Participants | Participants in which a device placement was attempted. |
| | |
| Primary | Procedural Endpoint: Descriptive Procedural Parameters - Use of Tack Sutures | Characterize procedural parameters including the use of tack sutures. | | Posted | | Count of Participants | | Participants | | During Procedure, Approximately 60 Minutes | | | | ID | Title | Description |
|---|
| OG000 | Treated Participants | Participants in which a device placement was attempted. |
| | |
| Primary | Procedural Endpoint: Descriptive Procedural Parameters - Muscle Dissection | Characterize procedural parameters, including muscle dissection across all participants. | | Posted | | Count of Participants | | Participants | | During Procedure, Approximately 60 Minutes | | | | ID | Title | Description |
|---|
| OG000 | Treated Participants | Participants in which a device placement was attempted. |
| | |
| Primary | Procedural Endpoint: Descriptive Procedural Parameters - Movement of Urethral Bulb While Tensioning | Characterize procedural parameters, including the movement of urethral bulb while tensioning in all participants. | | Posted | | Count of Participants | | Participants | | During Procedure, Approximately 60 Minutes | | | | ID | Title | Description |
|---|
| OG000 | Treated Participants | Participants in which a device placement was attempted. |
| | |
| Primary | Device Success as Defined as Successful Placement of the Device in Desired Position Peri-operatively | Summarize device success as defined as a successful placement of the device in a desired position, peri-operatively, in participants. | | Posted | | Count of Participants | | Participants | | During Procedure, Approximately 60 Minutes | | | | ID | Title | Description |
|---|
| OG000 | Treated Participants | Participants in which a device placement was attempted. |
| | |
| Secondary | Subject Satisfaction Endpoint: 1-Hour Pad Weight | Summarize subject satisfaction of 1-hour pad weight for participants. | Last observation carried forward (LOCF) and worst case scenario (WCS) data are derived from data from the 24 month visit | Posted | | Mean | Standard Deviation | grams | | Baseline to 24 month | | | | ID | Title | Description |
|---|
| OG000 | Treated Participants | Participants in which a device placement was attempted. |
| | |
| Secondary | Subject Satisfaction Endpoint: 24-Hour Pad Weight | Summarize subject satisfaction with 24-hour pad weight across participants. | LOCF and WCS data are derived from data from the 24 month visit | Posted | | Mean | Standard Deviation | grams | | Baseline to 24 month | | | | ID | Title | Description |
|---|
| OG000 | Treated Participants | Participants in which a device placement was attempted. |
| | |
| Secondary | Subject Satisfaction Endpoint: Percentage of Subjects Having a Decrease of Pad Weight of 25%, 50%, or 75% at Follow-Up. (1 Hour Pad Weight Test) | Summarize the percent of subjects that have a decrease of pad weight of 25%, 50%, or 75% at follow-up (1-hour pad weight test used). | | Posted | | Number | | participants | | Baseline to 24 month | | | | ID | Title | Description |
|---|
| OG000 | 3 Month | | | OG001 | 6 Month | | | OG002 | 12 Month | | | OG003 | 24 Month | | | OG004 | 24 Month LOCF | 24 Month Visit using Last Observation Carried Forward | | OG005 |
|
| Secondary | Subject Satisfaction Endpoint: Percentage of Subjects Having a Decrease of Pad Weight of 25%, 50%, or 75% at Follow-Up. (24 Hour Pad Weight Test) | Summarize the percent of subjects that have a decrease of pad weight of 25%, 50%, or 75% at follow-up (24-hour pad weight test used). | | Posted | | Number | | participants | | Baseline to 24 Month | | | | ID | Title | Description |
|---|
| OG000 | 3 Month | | | OG001 | 6 Month | | | OG002 | 12 Month | | | OG003 | 24 Month | | | OG004 | 24 Month LOCF | 24 Month Visit using Last Observation Carried Forward | | OG005 |
|
| Secondary | Subject Satisfaction Endpoint: Pads Per Day Use | Summarize the subject satisfaction using pads per day use collected in follow-up in participants. | LOCF and WCS data are derived from data from the 24 month visit | Posted | | Count of Participants | | Participants | | Baseline to 24 Months | | | | ID | Title | Description |
|---|
| OG000 | 0-1 PPD | | | OG001 | 2-3 PPD | | | OG002 | 4-5 PPD | | | OG003 | 6-7 PPD | | | OG004 | >= 10 PPD | Greater than or equal to 10 Pads per Day Use |
| |
| Secondary | Subject Satisfaction Endpoint: Quality of Life I-QOL Scores | The Incontinence Quality of Life (I-QOL) questionnaire contains 22 items, each with a 5-point Likert-type response scale, evaluating a subject's quality of life with respect to his urinary problems or incontinence. A possible total score can be 0-100, with a higher score meaning less problems. | Number of subjects that did not have test performed at follow-up visit. | Posted | | Mean | Standard Deviation | score | | Baseline to 24 Months | | | | ID | Title | Description |
|---|
| OG000 | Treated Participants | Participants in which a device placement was attempted. |
| |
| Secondary | Subject Satisfaction Endpoint: Quality of Life International Consultation on Incontinence Questionnaire Short-Form (ICIQ-SF) Scores | The ICIQ-SF questionnaire evaluates the impact of urinary incontinence on quality of life through four questions that evaluate the frequency, severity and impact of urinary incontinence. A set of eight self-diagnosis items related to the causes or situations of urinary incontinence experienced by the subject are also assessed. Scores may range from 0 to 21. Improvement in the subject's quality of life from baseline to follow-up is indicated by a decrease in the ICIQ-SF score. | Number of subjects that did not have test performed at follow-up visit. | Posted | | Mean | Standard Deviation | score | | Baseline to 24 Months | | | | ID | Title | Description |
|---|
| OG000 | Treated Participants | Participants in which a device placement was attempted. |
| |
| Post-Hoc | Uroflow Studies: Peak Flow Rate | Baseline uroflow measurements including peak flow rates, average flow rates, voided volume, and post-void residual were compared to follow-up results at 3, 6, 12, and 24 months. | Number of subjects that did not have test performed at follow-up visit. | Posted | | Mean | Standard Deviation | ml/sec | | Baseline to 24 month | | | | ID | Title | Description |
|---|
| OG000 | Treated Participants | Participants in which a device placement was attempted. |
| | |
| Post-Hoc | Uroflow Studies: Average Flow Rates | Baseline uroflow measurements including peak flow rates, average flow rates, voided volume, and post-void residual were compared to follow-up results at 3, 6, 12, and 24 months. | Number of subjects that did not have test performed at follow-up visit. | Posted | | Mean | Standard Deviation | ml/sec | | Baseline to 24 Month | | | | ID | Title | Description |
|---|
| OG000 | Treated Participants | Participants in which a device placement was attempted. |
| | |
| Post-Hoc | Uroflow Studies: Voided Volume | Baseline uroflow measurements including peak flow rates, average flow rates, voided volume, and post-void residual were compared to follow-up results at 3, 6, 12, and 24 months. | Number of subjects that did not have test performed at follow-up visit. | Posted | | Mean | Standard Deviation | ml | | Baseline to 24 Months | | | | ID | Title | Description |
|---|
| OG000 | Treated Participants | Participants in which a device placement was attempted. |
| | |
| Post-Hoc | Uroflow Studies: Post-Void Residual | Baseline uroflow measurements including peak flow rates, average flow rates, voided volume, and post-void residual were compared to follow-up results at 3, 6, 12, and 24 months. | Number of subjects that did not have test performed at follow-up visit. | Posted | | Mean | Standard Deviation | ml | | Baseline to 24 Months | | | | ID | Title | Description |
|---|
| OG000 | Treated Participants | Participants in which a device placement was attempted. |
| | |
| Post-Hoc | Urodynamic Results: Bladder Capacity | Baseline urodynamic measurements including bladder capacity, maximum detrusor pressure, detrusor pressure at maximum flow, and detrusor instability were measured at baseline and at 6-month follow-up. | Number of subjects that did not have test performed at follow-up visit. | Posted | | Mean | Standard Deviation | ml | | Baseline and 6 Months Post implant | | | | ID | Title | Description |
|---|
| OG000 | Treated Participants | Participants in which a device placement was attempted. |
| | |
| Post-Hoc | Urodynamics Results: Maximum Detrusor Pressure | Baseline urodynamic measurements including bladder capacity, maximum detrusor pressure, detrusor pressure at maximum flow, and detrusor instability were measured at baseline and at 6-month follow-up. Maximum detrusor pressure is measured during a urodynamic study when tension is applied to the bladder wall (detrusor muscles) by filling the bladder to capacity with saline water and observing the detrusor muscle during filling of the bladder and voiding of the saline water. | Number of subjects that did not have test performed at follow-up visit. | Posted | | Mean | Standard Deviation | cm H2O | | Baseline and 6 Months Post Implant | | | | ID | Title | Description |
|---|
| OG000 | Treated Participants | Participants in which a device placement was attempted. |
| |
| Post-Hoc | Urodynamics Results: Pdet at Qmax | Baseline urodynamic measurements including bladder capacity, maximum detrusor pressure, detrusor pressure at maximum flow, and detrusor instability were measured at baseline and at 6-month follow-up. Maximum detrusor pressure is measured during a urodynamic study when tension is applied to the bladder wall (detrusor muscles) by filling the bladder to capacity with saline water and observing the detrusor muscle during filling of the bladder and voiding of the saline water. Pdet at Qmax is the detrusor pressure at maximal flow rate when the bladder is full and the patient begins voiding. | Number of subjects that did not have test performed at follow-up visit. | Posted | | Mean | Standard Deviation | cm H20 | | Baseline and 6 Months Post Implant | | | | ID | Title | Description |
|---|
| OG000 | Treated Participants | Participants in which a device placement was attempted. |
| |
| Post-Hoc | Urodynamics Results: Detrusor Instability, Started at Filling Volume | Baseline urodynamic measurements including bladder capacity, maximum detrusor pressure, detrusor pressure at maximum flow, and detrusor instability were measured at baseline and at 6-month follow-up. Detrusor instability occurs when the detrusor muscle is unstable and spontaneously contracts the bladder. The measure data table shows the mean volume at the start of the urodynamic measurement study for patients with detrusor instability. | Number of subjects that did not have test performed at follow-up visit. | Posted | | Mean | Standard Deviation | ml | | Baseline and 6 Months Post Implant | | | | ID | Title | Description |
|---|
| OG000 | Treated Participants | Participants in which a device placement was attempted. |
| |
| Post-Hoc | Urodynamics Results: Detrusor Instability, Max Pdet | Baseline urodynamic measurements including bladder capacity, maximum detrusor pressure, detrusor pressure at maximum flow, and detrusor instability were measured at baseline and at 6-month follow-up. Maximum detrusor pressure is measured during a urodynamic study when tension is applied to the bladder wall (detrusor muscles) by filling the bladder to capacity with saline water and observing the detrusor muscle during filling of the bladder and voiding of the saline water. Pdet at Qmax is the detrusor pressure at maximal flow rate when the bladder is full and the patient begins voiding. Detrusor instability occurs when the detrusor muscle is unstable and spontaneously contracts the bladder. The outcome measure data table shows the Pdet for patients with detrusor instability. | Number of subjects that did not have test performed at follow-up visit. | Posted | | Mean | Standard Deviation | cm H2O | | Baseline and 6 Months Post Implant | | | | ID | Title | Description |
|---|
| OG000 | Treated Participants | Participants in which a device placement was attempted. |
| |
| Post-Hoc | Urodynamics Results: Abnormal Cystometrogram, Abnormal End Fill Pressure | Baseline urodynamic measurements including bladder capacity, maximum detrusor pressure, detrusor pressure at maximum flow, and detrusor instability were measured at baseline and at 6-month follow-up. Abnormal graphical representation of bladder pressure during urodynamics testing which is when the bladder is filled with saline water. | Number of subjects that did not have test performed at follow-up visit. | Posted | | Mean | Standard Deviation | cm H2O | | Baseline and 6 Months Post Implant | | | | ID | Title | Description |
|---|
| OG000 | Treated Participants | Participants in which a device placement was attempted. |
| |
| Post-Hoc | Urodynamic Results: Abdominal Leak Point Pressure | Abdominal leak point pressure (ALPP) is one indicator of improvement in continence symptoms. Abdominal leak point pressure was collected at baseline and 6-month follow-up as part of the urodynamic assessment. | 18 participants did not have 6-month follow-up data | Posted | | Number | | participants | | Baseline and 6 Months Post Implant | | | | ID | Title | Description |
|---|
| OG000 | Treated Participants | Participants in which a device placement was attempted. |
| | |
| Secondary | Subject Satisfaction Endpoint: Quality of Life UCLA (University of California Los Angeles) / RAND (RAND Corporation) Scores | Improvement in the subject's quality of life from baseline to follow-up is indicated by an increase in the UCLA/RAND urinary function score. Scores may range from 0 to 100. | Number of subjects that did not have test performed at follow-up visit. | Posted | | Mean | Standard Deviation | score | | Baseline to 24 Months | | | | ID | Title | Description |
|---|
| OG000 | Treated Participants | Participants in which a device placement was attempted. |
| |
| Secondary | Subject Satisfaction Endpoint: Physician Evaluation of Subject's Incontinence Status | Physician evaluation of subject's incontinence status at 6 weeks and subsequent follow-up evaluations | | Posted | | Count of Participants | | Participants | | 6 Weeks post implant to 24 Months | | | | ID | Title | Description |
|---|
| OG000 | Completely Dry | | | OG001 | Substantially Improved | Defined as "May have periodic leakage of small amounts but additional protection not needed". | | OG002 | Some Additional Protection May be Required | Defined as "Up to three pads per day may be needed or may wet themselves not more than once weekly". | | OG003 | Substantially or Totally Incontinent | Defined as "Will require more than three pads per day or may wet themselves two or more times per week". |
| |
| Secondary | Procedural and Device Complication Rates | Percentage of participants with serious and non-serious adverse events. | | Posted | | Number | | percentage of participants | | Procedure to 24 Months Post implant | | | | ID | Title | Description |
|---|
| OG000 | Treated Participants | Participants in which a device placement was attempted. |
| | | Title | Denominators | Categories |
|---|
|